112eur
1,4 %
Date:2025-10-10Time:18:00:00Latest report:Q1-2025List:First NorthTicker:NANOFH
Market Cap:96 meurEnterprise Value:65 meurNet Sales:3,05 meurEarnings:-21,8 meurEmployees:0ISIN:FI4000330972

Ratios

10-year key figure history for Nanoform turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanoform with index and moving average MA50 and MA200.

Stockprice:1,12
MA50:0,96
MA200:1,07
Price/MA200:5,0 %
RSI (14):60,7
Price/MA50:16,9 %

Description

Nanoform Finland operates in the medical technology sector. The company specializes in research and development of nanoparticle technology used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. Customers consist of players in the global pharmaceutical industry, with the largest operations in the Nordic market. Nanoform Finland is headquartered in Helsinki.

Pharmaceuticals